Mercado mundial de tratamiento de trastornos de parafilia: tendencias de la industria y pronóstico hasta 2029

Análisis y perspectivas del mercado global de tratamiento de trastornos de parafilia

Se espera que el mercado de tratamiento de trastornos de parafilia gane crecimiento en el período de pronóstico de 2022 a 2029. Data Bridge Market Research analiza el mercado para tener en cuenta un crecimiento a una CAGR del 7,10 % en el período de pronóstico mencionado anteriormente.

Las parafilias son deseos, impulsos, fantasías o conductas sexuales de carácter persistente y recurrente que involucran objetos, actividades o incluso situaciones de naturaleza anormal. Un trastorno parafílico puede desarrollarse si la parafilia causa sufrimiento, angustia o deterioro funcional en la vida de las personas afectadas o de otras personas, incluso si no es intrínsecamente anormal. La pedofilia, el exhibicionismo, el voyeurismo, el sadismo sexual, el masoquismo sexual, el froteurismo, el fetichismo y el fetichismo travesti se encuentran entre las ocho parafilias clasificadas en el DSM V.

El aumento de la prevalencia de los trastornos parafílicos actuará como un factor importante que dará como resultado la expansión del crecimiento del mercado. Otro factor significativo que influye en la tasa de crecimiento del mercado de tratamiento de los trastornos parafílicos es el aumento del gasto en atención médica. Además, el avance en la tecnología médica, las crecientes iniciativas de las organizaciones públicas y privadas para difundir la conciencia y el aumento de la financiación gubernamental son los factores que expandirán el mercado de tratamiento de los trastornos parafílicos. Otros factores, como el aumento de la demanda de terapias efectivas y el aumento de la población geriátrica, tendrán un impacto positivo en la tasa de crecimiento del mercado de tratamiento de los trastornos parafílicos. Además, los altos ingresos disponibles y el cambio en el estilo de vida darán como resultado la expansión del mercado de tratamiento de los trastornos parafílicos.

Moreover, the rise in the research and development activities and launch of effective therapies will provide beneficial opportunities for the paraphilia disorder treatment market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate paraphilia disorder treatment market in future.

However, high cost associated with the treatment and lack of infrastructure in low-income countries will impede the growth rate of paraphilia disorder treatment market. Additionally, complications involved with this disease will hinder the paraphilia disorder treatment market growth. Less awareness will further challenge the market in the forecast period mentioned above.

This paraphilia disorder treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Paraphilia disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Paraphilia Disorder Treatment Market Scope and Market Size

The paraphilia disorder treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the paraphilia disorder treatment market is segmented into pedophilia, exhibitionism, voyeurism, sexual sadism, sexual masochism, frotteurism, fetishism, and transvestic fetishism.
• On the basis of treatment, the paraphilia disorder treatment market is segmented into medication, cognitive behavioral therapy and others. The segment of medication is further sub-segmented into selective serotonin re-uptake inhibitors (SSRIs) and others. The segment selective serotonin re-uptake inhibitors (SSRIs) is divided into fluoxetine, sertraline, paroxetine, citalopram, escitalopram and vortioxetine.
• On the basis of diagnosis, the paraphilia disorder treatment market is segmented into physical examination, imaging tests, laboratory tests and others. The segment of imaging tests is further sub-segmented into ultrasonography and angiography.
• On the basis of dosage, the paraphilia disorder treatment market is segmented into injection, tablets and others.
• On the basis of route of administration, the paraphilia disorder treatment market is segmented into oral, intravenous and others.
• On the basis of end-users, the paraphilia disorder treatment market is segmented into clinic, hospital and others.

The paraphilia disorder treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Paraphilia Disorder Treatment Market Country Level Analysis

Paraphilia disorder treatment market is analyzed and market size information is provided by the country, type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the paraphilia disorder treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the paraphilia disorder treatment market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing patient pool, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Paraphilia disorder treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Paraphilia Disorder Treatment Market Share Analysis

El panorama competitivo del mercado de tratamiento de trastornos parafílicos proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, las líneas de ensayos clínicos, las aprobaciones de productos, las patentes, la amplitud y la extensión de los productos, el dominio de las aplicaciones, la curva de la línea de vida de la tecnología. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con la investigación de mercado de tratamiento de trastornos parafílicos.

Algunos de los principales actores que operan en el mercado de tratamiento de trastornos de parafilia son Novartis AG, AstraZeneca, Johnson & Johnson Private Limited, AbbVie Inc., Eisai Co., Ltd., Pfizer Inc., GlaxoSmithKline plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Mylan NV, Allergan, Sun Pharmaceutical Industries Ltd., Sanofi, Aurobindo Pharma, Cipla Inc., Abbott, Merck & Co., Inc., Bristol-Myers Squibb Company, Dr. Reddy's Laboratories Ltd., AstraZeneca, WOCKHARDT y Echo Pharmaceuticals BV, entre otros.

SKU-67811